KLUS PHARMA INC.
2Patents
2Active
2Granted
43Portfolio score
Filing activity: Dec 19, 2019 → Apr 6, 2020
Most-cited patents
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US12258419B2 | Anti-FXI/FXIa antibody and use thereof | Physics | 0 | Active |
| US12297265B2 | Antibody and use thereof | Chemistry; Metallurgy | 0 | Active |
Source: USPTO / EPO open patent data. Counts and citation impact are objective bibliographic measures.